Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222337 · ClinicalTrials.gov registry record · NA
Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT02222337 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 272 participants.
The verdict
NCT02222337, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
Latina breast cancer survivors report lower quality of life (QOL) than non-Latina survivors. Lower QOL can lead to poorer functional and cancer-related survival outcomes. The friends and family of Latina cancer patients are also impacted by a loved one's diagnosis of breast cancer. Through strong community-academic partnerships, the investigators seek to improve the QOL of Latina survivors and their caregivers with a culturally-relevant intervention. In this project, the investigators plan to further develop and refine the intervention and then test it through a randomized controlled trial. First, the investigators will conduct in-depth qualitative interviews with 10 survivor-caregiver dyads (pairs) to see if the intervention fits for survivors and caregivers in different parts of the country. Then, the investigators will revise the intervention. Finally, the investigators will test the intervention in a randomized controlled trial. The investigators will invite 125 survivor-caregiver dyads to be a part of our study. Half will be asked to complete the intervention and half will be offered the usual services, such as support groups. The information learned from this study could help improve the quality of life in Latina breast cancer survivors and their caregivers. Physicians, survivors, and community groups can also benefit from this study because they will have more information about the needs of Latina breast cancer survivors. The investigators hope to use the information to help other types of survivors and caregivers in the future.
Interventions
- BEHAVIORAL Nueva Vida Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2013-05 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02222337
The ClinicalTrials.gov registry entry for NCT02222337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nueva Vida Intervention is the first listed.
NCT02222337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02222337 about?
NCT02222337 is a clinical study titled "Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers". Latina breast cancer survivors report lower quality of life (QOL) than non-Latina survivors. Lower QOL can lead to poorer functional and cancer-related survival outcomes. The friends and family of Latina cancer patients are also impacted by a loved one's diagnosis of breast cancer. Through strong co...
What is the current status of trial NCT02222337?
This trial is currently completed. It is a NA study. The enrollment target is 272 participants. The study started on 2013-05. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02222337?
The interventions under investigation include: Nueva Vida Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02222337?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.